Stock Events

Stock Events

Sirona Biochem 

$0.01
14
+$0+0% Wednesday 13:30

Statistics

Day High
0.01
Day Low
0.01
52W High
0.02
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
1.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29SepExpected
Q2 2020
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
-0.0012

Financials

-7,189.29%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
51,696.48Revenue
-3.72MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SRBCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
L`Oreal
LRLCY
Mkt Cap236.52B
L'Oréal operates in the beauty and skincare sector, directly competing with Sirona Biochem's cosmetic ingredient development.
Estee Lauder Cos.
EL
Mkt Cap28.68B
Estée Lauder competes in the development and marketing of skincare, makeup, fragrance, and hair care products, similar to Sirona's focus areas.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its consumer health division, competes in the skincare market, particularly in the development of beauty and personal care products.
Procter & Gamble
PG
Mkt Cap342.91B
Procter & Gamble competes across various segments including skincare and personal care, overlapping with Sirona Biochem's market.
Unitedhealth Group
UNH
Mkt Cap334.93B
Unilever, with its vast portfolio of personal care and beauty brands, competes in the same market as Sirona Biochem.
Colgate-Palmolive
CL
Mkt Cap70.01B
Colgate-Palmolive, through its personal care products, competes in the oral and skin care markets, relevant to Sirona's interests.
Kimberly-Clark
KMB
Mkt Cap32.42B
Kimberly-Clark, with products in the personal care segment, competes indirectly by offering skincare products.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline, through its consumer healthcare division, competes in the oral health and nutritional products market, indirectly competing with Sirona.
Novartis
NVS
Mkt Cap279.67B
Novartis, a pharmaceutical company, competes indirectly through its dermatology division, focusing on skin conditions that could overlap with Sirona's cosmetic ingredient innovations.

About

There is no Profile data available for ZSB.SG.
Show more...
CEO
Dr. Howard J. Verrico M.D., Ph.D.
Employees
10
Country
Canada
ISIN
CA82967M1005

Listings

MU
DE
ZSB.MU
STU
DE
ZSB.STU
OTC Link
US
SRBCF

0 Comments

Share your thoughts

FAQ

What is Sirona Biochem stock price today?▼
The current price of SRBCF is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Sirona Biochem stock price performance more closely on the chart.
What is Sirona Biochem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sirona Biochem stocks are traded under the ticker SRBCF.
What is Sirona Biochem market cap?▼
Today Sirona Biochem has the market capitalization of 1.32M
What were Sirona Biochem earnings last quarter?▼
SRBCF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sirona Biochem revenue for the last year?▼
Sirona Biochem revenue for the last year amounts to 51,696.48 USD.
What is Sirona Biochem net income for the last year?▼
SRBCF net income for the last year is -3.72M USD.
How many employees does Sirona Biochem have?▼
As of May 06, 2026, the company has 10 employees.
In which sector is Sirona Biochem located?▼
Sirona Biochem operates in the Health & Wellness sector.
When did Sirona Biochem complete a stock split?▼
Sirona Biochem has not had any recent stock splits.
Where is Sirona Biochem headquartered?▼
Sirona Biochem is headquartered in Vancouver, Canada.